J. Mcgregor

792 total citations
13 papers, 422 citations indexed

About

J. Mcgregor is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, J. Mcgregor has authored 13 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Rheumatology and 3 papers in Immunology. Recurrent topics in J. Mcgregor's work include Vasculitis and related conditions (10 papers), Otitis Media and Relapsing Polychondritis (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). J. Mcgregor is often cited by papers focused on Vasculitis and related conditions (10 papers), Otitis Media and Relapsing Polychondritis (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). J. Mcgregor collaborates with scholars based in United States, Denmark and Mexico. J. Mcgregor's co-authors include Susan L. Hogan, Ronald J. Falk, Yichun Hu, Caroline J. Poulton, Patrick H. Nachman, Caroline E. Jennette, J. Charles Jennette, J. Richard Landis, Rennie L. Rhee and Peter A. Merkel and has published in prestigious journals such as Clinical Journal of the American Society of Nephrology, Nature Reviews Nephrology and Seminars in Arthritis and Rheumatism.

In The Last Decade

J. Mcgregor

13 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Mcgregor United States	7	358	165	156	112	84	13	422
Michael J. Kemna Netherlands	10	325 0.9×	152 0.9×	113 0.7×	127 1.1×	140 1.7×	13	454
Eduard Mirapeix Spain	8	252 0.7×	91 0.6×	70 0.4×	55 0.5×	96 1.1×	9	299
Jaume Vilaseca Spain	5	317 0.9×	209 1.3×	82 0.5×	85 0.8×	21 0.3×	6	367
Martin Lockwood United Kingdom	8	262 0.7×	160 1.0×	57 0.4×	38 0.3×	107 1.3×	11	352
Brian H. Ewert United States	5	279 0.8×	78 0.5×	75 0.5×	142 1.3×	74 0.9×	6	329
J Zabka Czechia	10	158 0.4×	99 0.6×	61 0.4×	53 0.5×	42 0.5×	33	318
D. Schaumann Germany	6	171 0.5×	93 0.6×	57 0.4×	56 0.5×	68 0.8×	12	308
J. Henes Germany	8	152 0.4×	126 0.8×	56 0.4×	47 0.4×	42 0.5×	19	261
John McLaren United Kingdom	8	152 0.4×	177 1.1×	83 0.5×	56 0.5×	36 0.4×	10	292
P. Macchioni Italy	13	204 0.6×	242 1.5×	130 0.8×	58 0.5×	24 0.3×	27	380

Countries citing papers authored by J. Mcgregor

Since Specialization

Citations

This map shows the geographic impact of J. Mcgregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mcgregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mcgregor more than expected).

Fields of papers citing papers by J. Mcgregor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mcgregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mcgregor. The network helps show where J. Mcgregor may publish in the future.

Co-authorship network of co-authors of J. Mcgregor

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mcgregor. A scholar is included among the top collaborators of J. Mcgregor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mcgregor. J. Mcgregor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chanouzas, Dimitrios, J. Mcgregor, Peter Nightingale, et al.. (2019). Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study. BMC Nephrology. 20(1). 58–58. 62 indexed citations

Roberts, Courtney, Carolyn T. Thorpe, Joshua M. Thorpe, et al.. (2019). Economic and objective burden of caregiving on informal caregivers of patients with systemic vasculitis. Musculoskeletal Care. 17(2). 282–287. 4 indexed citations

Thorpe, Carolyn T., Joshua M. Thorpe, Tao Jiang, et al.. (2017). Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis. Seminars in Arthritis and Rheumatism. 47(4). 507–519. 7 indexed citations

Rhee, Rennie L., Susan L. Hogan, Caroline J. Poulton, et al.. (2016). Trends in Long‐Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Renal Disease. Arthritis & Rheumatology. 68(7). 1711–1720. 94 indexed citations

Geetha, Duvuru, Caroline J. Poulton, Yichun Hu, et al.. (2013). Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Seminars in Arthritis and Rheumatism. 43(6). 778–783. 9 indexed citations

Free, Meghan E., Donna O. Bunch, J. Mcgregor, et al.. (2013). ANCA disease patients have defective Treg function exacerbated by expansion of a suppression-resistant effector population. La Presse Médicale. 42(4). 656–656. 1 indexed citations

Poulton, Caroline J., Patrick H. Nachman, Yichun Hu, et al.. (2013). Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.. Clinical and Experimental Rheumatology. 31(1 Suppl 75). S32–7. 19 indexed citations

Free, Meghan E., Donna O. Bunch, J. Mcgregor, et al.. (2013). Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Have Defective Treg Cell Function Exacerbated by the Presence of a Suppression‐Resistant Effector Cell Population. Arthritis & Rheumatism. 65(7). 1922–1933. 124 indexed citations

Hogan, Susan L., J. Mcgregor, Caroline J. Poulton, et al.. (2013). Functionally effect regulatory B cells in patients with active ANCA vasculitis. La Presse Médicale. 42(4). 763–763. 1 indexed citations

10.

Berg, Elisabeth A., et al.. (2013). What everybody is doing but no one is talking about: Complementary and alternative medicine (CAM) prevalence in the ANCA SVV population. La Presse Médicale. 42(4). 775–775. 1 indexed citations

11.

Mcgregor, J., Caroline J. Poulton, Jason M. Kidd, et al.. (2013). Infectious complications related to treatment in an inception cohort of antineutrophil cytoplasmic antibody associated vasculitis. La Presse Médicale. 42(4). 767–767. 1 indexed citations

12.

Mcgregor, J. & Ronald J. Falk. (2012). The elusive optimal induction strategy for vasculitis. Nature Reviews Nephrology. 8(4). 195–196. 4 indexed citations

13.

Mcgregor, J., Susan L. Hogan, Yichun Hu, et al.. (2011). Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease. Clinical Journal of the American Society of Nephrology. 7(2). 240–247. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact